Application no. and date | 14168117.1 (espacenet) (Federated) (European Patent Register), 20100706 | Patent/reg. no. and date | DK/EP 3072890, 20181017 | Publication date | 20160928 | Priority no. and date | US 223684 P, 20090707, US 247448 P, 20090930, US 318195 P, 20100326 | EP pub. no. and date |
EP 3072890 20160928 | Effective date | | Applicant/owner | MEI Pharma, Inc., 3611 Valley Centre Drive, Suite 500
San Diego, CA 92130, US | Applicant ref. no. | P67106DK01 | Inventor | TSANG, Kit, Yee, 9 Bampton Rise Howick
Auckland 2013, NZ, GIDDENS, Anna, Claire, 7/1 Ruskin Street Parnell
Auckland 1052, NZ, GAMAGE, Swarnalatha, Akuratiya, No. 6, Korau Road Greenlane
Auckland 1051, NZ, REWCASTLE, Gordon Wiliam, 72 Esperance Road Glendowie
Auckland 1071, NZ | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/53 (2006.01) , A61P 35/00 (2006.01) , C07D 401/14 (2006.01) , C07D 403/04 (2006.01) , C07D 403/14 (2006.01) , C07D 487/04 (2006.01) | Title | Pyrimidinyl og 1,3,5-triazinylbenzimidazoler og deres anvendelse i kræftterapi | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|